High-performance hemostats are costly and import-dependent
Controlling bleeding quickly and safely is critical across dental and surgical settings, yet the best-performing hemostatic products are expensive and largely imported. The region needed a locally developed, high-performance, low-cost alternative built on protectable IP.
A pipeline of medical-device IP, made through licensing
InCurA develops high-performance, enhanced-efficacy medical devices with low-cost manufacturing, commercialized via license agreements. Its lead bleeding-control products are in partner manufacturing with Royah Pharmaceuticals in KSA, and its advanced wound-care line is licensed to industry partner Cigalah — the first hemostatic sponge line in MENA.
InCurA in action
ColiSorB and CurASeal: outperforming global brands
ColiSorB hemostatic sponges deliver up to 60x rapid blood absorption without pre-wetting, with superior mechanical stability, complete body absorption in under four days and full fibroblast cell viability. CurASeal's perforated, concave starch microparticles achieve the quickest clotting in narrow, hard-to-reach surgical sites — faster hemostasis and far lower blood loss than leading brands, with no cytotoxicity.
- ColiSorB absorption
- Up to 60x rapid blood absorption, no pre-wetting
- ColiSorB pricing
- USD 12–18 vs USD 20–27 for global comparators
- CurASeal hemostasis
- ~1 minute time to hemostasis; 88 mg total blood loss
- Biocompatibility
- No cytotoxicity; complete body absorption under 4 days
- Commercialization
- License manufacturing with Royah Pharma and Cigalah (GCC & Levant)
Creating impact where it matters most
Superior performance
Delivering faster absorption and clotting than established global products.
Lower cost of care
Pricing well below imported comparators while exceeding their performance.
Regional manufacturing
Producing locally through license agreements across GCC and Levant.
Expanding pipeline
Scaling from hemostatics into a multi-product advanced wound-care portfolio.
KAUST. On a mission for Saudi Arabia and the world.
Whether you’re a researcher, entrepreneur, industry partner or investor, we invite you to be part of the journey.
Partner With UsBuilding 34, KAUST Research & Technology Park, Thuwal 23955-6900, Kingdom of Saudi Arabia